STOK

Stoke TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-03

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

STOK vs peer average

43/100

STOK vs. peer average (D vs. D)

Grade spread

B 1 · C 5 · D 3 · F 2

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

INBX is the first available peer comparator.

Inhibrx Biosciences is a closer-size clinical biotech comp where valuation is also milestone-driven and commercial revenue is not the support; it is useful for binary-development and funding-risk framing, though the indication set is different.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerINBXInhibrx Biosciences

STOK

Stoke Therapeutics

INBX

Inhibrx Biosciences

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs INBX

STOK / INBX

Grade Position

Below peers

STOK vs. peer average (D vs. D)

43/100

Momentum

INBX

Value

STOK

Sentiment

STOK

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs STOK

INBX

40/100

Even

MESO

20/100

NBTX

60/100

-1

HRMY

Harmony Biosciences Holdings Inc Common

60/100

-1

CMPS

COMPASS Pathways Plc ADR

60/100

-1

INBX is the first peer returned for this comparison set.